109TH CONGRESS 
2D SESSION 
H. R. 6344
AN ACT 
To reauthorize the Office of National Drug Control Policy 
Act.
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled,
SECTION 1. SHORT TITLE, REFERENCE, AND TABLE OF 
CONTENTS. 
(a) SHORT TITLE.—This Act may be cited as the 
‘‘Office of National Drug Control Policy Reauthorization 
Act of 2006’’. 
(b) AMENDMENT OF OFFICE OF NATIONAL DRUG 
CONTROL POLICY REAUTHORIZATION ACT OF 1998.—Ex-
cept as otherwise expressly provided, whenever in this Act 
an amendment or repeal is expressed in terms of an 
amendment to, or repeal of, a section or other provision, 
the reference shall be considered to be made to a section 
or other provision of the Office of National Drug Control 
Policy Reauthorization Act of 1998 (Public Law 105–277; 
21 U.S.C. 1701 et seq.). 
(c) TABLE OF CONTENTS.—The table of contents for 
this Act is as follows:
Sec. 1. Short title, reference, and table of contents. 
TITLE I—ORGANIZATION OF OFFICE OF NATIONAL DRUG 
CONTROL POLICY AND ROLES AND RESPONSIBILITIES 
Sec. 101. Amendments to definitions. 
Sec. 102. Establishment of the Office of National Drug Control Policy. 
Sec. 103. Appointment and responsibilities of the Director. 
Sec. 104. Amendments to ensure coordination with other agencies. 
Sec. 105. Budgetary matters. 
TITLE II—THE NATIONAL DRUG CONTROL STRATEGY 
Sec. 201. Annual preparation and submission of National Drug Control Strat-
egy. 
Sec. 202. Performance measurements. 
Sec. 203. Annual report requirement. 
TITLE III—HIGH INTENSITY DRUG TRAFFICKING AREAS 
Sec. 301. High Intensity Drug Trafficking Areas Program. 
Sec. 302. Funding for certain high intensity drug trafficking areas.
Sec. 303. Assessment. 
TITLE IV—TECHNOLOGY 
Sec. 401. Counterdrug Technology Assessment Center. 
TITLE V—NATIONAL YOUTH MEDIA CAMPAIGN 
Sec. 501. National Youth Anti-Drug Media Campaign. 
TITLE VI—AUTHORIZATIONS AND EXTENSION OF TERMINATION 
DATE 
Sec. 601. Authorization of appropriations. 
Sec. 602. Extension of termination date. 
TITLE VII—ANTI-DOPING AGENCY 
Sec. 701. Designation of United States Anti-Doping Agency. 
Sec. 702. Records, audit, and report. 
Sec. 703. Authorization of appropriations. 
TITLE VIII—DRUG-FREE COMMUNITIES 
Sec. 801. Reauthorization. 
Sec. 802. Suspension of grants. 
Sec. 803. Grant award increase. 
Sec. 804. Prohibition on additional eligibility criteria. 
Sec. 805. National Community Anti-Drug Coalition Institute. 
TITLE IX—NATIONAL GUARD COUNTERDRUG SCHOOLS 
Sec. 901. National Guard counterdrug schools. 
TITLE X—NATIONAL METHAMPHETAMINE INFORMATION 
CLEARINGHOUSE ACT OF 2006
Sec. 1001. Short title. 
Sec. 1002. Definitions. 
Sec. 1003. Establishment of clearinghouse and advisory council. 
Sec. 1004. NMIC requirements and review. 
Sec. 1005. Authorization of appropriations. 
TITLE XI—MISCELLANEOUS PROVISIONS 
Sec. 1101. Repeals. 
Sec. 1102. Controlled Substances Act amendments. 
Sec. 1103. Report on law enforcement intelligence sharing. 
Sec. 1104. Requirement for South American heroin strategy. 
Sec. 1105. Model acts. 
Sec. 1106. Study on iatrogenic addiction associated with prescription opioid an-
algesic drugs. 
Sec. 1107. Requirement for strategy to stop Internet advertising of prescription 
medicines without a prescription. 
Sec. 1108. Requirement for study on diversion and inappropriate uses of pre-
scription drugs. 
Sec. 1109. Requirement for Afghan Heroin Strategy. 
Sec. 1110. Requirement for Southwest Border Counternarcotics Strategy.
Sec. 1111. Requirement for Scientific Study of Mycoherbicide in Illicit Drug 
Crop Eradication. 
Sec. 1112. Requirement for Study of State Precursor Chemical Control Laws. 
Sec. 1113. Requirement for Study of Drug Endangered Children Programs. 
Sec. 1114. Study on drug court hearings in nontraditional places. 
Sec. 1115. Report on tribal Government participation in HIDTA process. 
Sec. 1116. Report on school drug testing. 
Sec. 1117. Report on ONDCP performance bonuses. 
Sec. 1118. Requirement for disclosure of Federal sponsorship of all Federal ad-
vertising or other communication materials. 
Sec. 1119. Awards for demonstration programs by local partnerships to coerce 
abstinence in chronic hard-drug users under community super-
vision through the use of drug testing and sanctions. 
Sec. 1120. Policy relating to syringe exchange programs.
TITLE I—ORGANIZATION OF OF-
FICE 
OF 
NATIONAL 
DRUG 
CONTROL POLICY AND ROLES 
AND RESPONSIBILITIES 
SEC. 101. AMENDMENTS TO DEFINITIONS. 
(a) DEMAND REDUCTION.—Section 702(1) is amend-
ed—
(1) in subparagraph (F), by striking ‘‘and’’ 
after the semicolon; 
(2) in paragraph (G), by striking the period at 
the end and inserting ‘‘, including the testing of em-
ployees;’’; and 
(3) by adding at the end the following: 
‘‘(H) interventions for drug abuse and de-
pendence; 
‘‘(I) international drug control coordina-
tion and cooperation with respect to activities 
described in this paragraph; and
‘‘(J) international drug abuse education, 
prevention, treatment, research, rehabilitation 
activities, and interventions for drug abuse and 
dependence.’’. 
(b) NATIONAL DRUG CONTROL PROGRAM.—Section 
702(6) is amended by adding before the period the fol-
lowing: ‘‘, including any activities involving supply reduc-
tion, demand reduction, or State, local, and tribal affairs’’. 
(c) PROGRAM CHANGE.—Section 702(7) is amended 
by—
(1) striking ‘‘National Foreign Intelligence Pro-
gram,’’ and inserting ‘‘National Intelligence Pro-
gram,’’; and 
(2) inserting after ‘‘Related Activities,’’ the fol-
lowing: ‘‘or (for purposes of section 704(d)) an agen-
cy that is described in section 530C(a) of title 28, 
United States Code,’’. 
(d) OFFICE.—Section 702(9) is amended by striking 
‘‘implicates’’ and inserting ‘‘indicates’’. 
(e) STATE, LOCAL, AND TRIBAL AFFAIRS.—Para-
graph (10) of section 702 is amended to read as follows: 
‘‘(10) STATE, LOCAL, AND TRIBAL AFFAIRS.—
The term ‘State, local, and tribal affairs’ means do-
mestic activities conducted by a National Drug Con-
trol Program agency that are intended to reduce the 
availability and use of illegal drugs, including—
‘‘(A) coordination and enhancement of 
Federal, State, local, and tribal law enforce-
ment drug control efforts; 
‘‘(B) coordination and enhancement of ef-
forts among National Drug Control Program 
agencies and State, local, and tribal demand re-
duction and supply reduction agencies; 
‘‘(C) coordination and enhancement of 
Federal, State, local, and tribal law enforce-
ment initiatives to gather, analyze, and dissemi-
nate information and law enforcement intel-
ligence relating to drug control among domestic 
law enforcement agencies; and 
‘‘(D) other coordinated and joint initiatives 
among Federal, State, local, and tribal agencies 
to promote comprehensive drug control strate-
gies designed to reduce the demand for, and the 
availability of, illegal drugs.’’. 
(f) SUPPLY REDUCTION.—Section 702(11) is amend-
ed to read as follows: 
‘‘(11) SUPPLY REDUCTION.—The term ‘supply 
reduction’ means any activity or program conducted 
by a National Drug Control Program agency that is
intended to reduce the availability or use of illegal 
drugs in the United States or abroad, including—
‘‘(A) law enforcement outside the United 
States; 
‘‘(B) source country programs, including 
economic development programs primarily in-
tended to reduce the production or trafficking 
of illicit drugs; 
‘‘(C) activities to control international traf-
ficking in, and availability of, illegal drugs, in-
cluding—
‘‘(i) accurate assessment and moni-
toring of international drug production and 
interdiction programs and policies; and 
‘‘(ii) coordination and promotion of 
compliance with international treaties re-
lating to the production, transportation, or 
interdiction of illegal drugs; 
‘‘(D) activities to conduct and promote 
international law enforcement programs and 
policies to reduce the supply of drugs; and 
‘‘(E) activities to facilitate and enhance the 
sharing of domestic and foreign intelligence in-
formation among National Drug Control Pro-
gram agencies, relating to the production and
trafficking of drugs in the United States and in 
foreign countries.’’. 
(g) DEFINITIONS OF APPROPRIATE CONGRESSIONAL 
COMMITTEES AND LAW ENFORCEMENT.—Section 702 is 
amended by adding at the end the following: 
‘‘(12) APPROPRIATE CONGRESSIONAL COMMIT-
TEES.—Except where otherwise provided, the term 
‘appropriate congressional committees’ means the 
Committee on the Judiciary, the Committee on Ap-
propriations, and the Caucus on International Nar-
cotics Control of the Senate and the Committee on 
Government Reform, the Committee on the Judici-
ary, and the Committee on Appropriations of the 
House of Representatives. 
‘‘(13) LAW ENFORCEMENT.—The term ‘law en-
forcement’ or ‘drug law enforcement’ means all ef-
forts by a Federal, State, local, or tribal government 
agency to enforce the drug laws of the United States 
or any State, including investigation, arrest, pros-
ecution, and incarceration or other punishments or 
penalties.’’. 
SEC. 102. ESTABLISHMENT OF THE OFFICE OF NATIONAL 
DRUG CONTROL POLICY. 
(a) RESPONSIBILITIES.—Section 703(a) is amended 
to read as follows:
‘‘(a) ESTABLISHMENT OF OFFICE.—There is estab-
lished in the Executive Office of the President an Office 
of National Drug Control Policy, which shall—
‘‘(1) develop national drug control policy; 
‘‘(2) coordinate and oversee the implementation 
of the national drug control policy; 
‘‘(3) assess and certify the adequacy of Na-
tional Drug Control Programs and the budget for 
those programs; and 
‘‘(4) evaluate the effectiveness of the national 
drug control policy and the National Drug Control 
Program agencies’ programs, by developing and ap-
plying specific goals and performance measure-
ments.’’. 
(b) POSITIONS.—Section 703(b) is amended to read 
as follows: 
‘‘(b) DIRECTOR OF NATIONAL DRUG CONTROL POL-
ICY AND DEPUTY DIRECTORS.—
‘‘(1) DIRECTOR.—There shall be a Director of 
National Drug Control Policy who shall head the Of-
fice (referred to in this Act as the ‘Director’) and 
shall hold the same rank and status as the head of 
an executive department listed in section 101 of title 
5, United States Code.
‘‘(2) DEPUTY
DIRECTOR.—There shall be a 
Deputy Director of National Drug Control Policy 
who shall report directly to the Director (referred to 
in this Act as the ‘Deputy Director’). 
‘‘(3) OTHER DEPUTY DIRECTORS.—
‘‘(A) IN GENERAL.—There shall be a Dep-
uty Director for Demand Reduction, a Deputy 
Director for Supply Reduction, and a Deputy 
Director for State, Local, and Tribal Affairs. 
‘‘(B) REPORTING.—The Deputy Director 
for Demand Reduction, the Deputy Director for 
Supply Reduction, and the Deputy Director for 
State, Local, and Tribal Affairs shall report di-
rectly to the Deputy Director of the Office of 
National Drug Control Policy. 
‘‘(C) DEPUTY DIRECTOR FOR DEMAND RE-
DUCTION.—The Deputy Director for Demand 
Reduction shall be responsible for the activities 
in subparagraphs (A) through (H) of section 
702(l). 
‘‘(D) DEPUTY DIRECTOR FOR SUPPLY RE-
DUCTION.—The Deputy Director for Supply 
Reduction shall—
‘‘(i) have substantial experience and 
expertise in drug interdiction and other 
supply reduction activities; and 
‘‘(ii) be responsible for the activities 
in subparagraphs (A) through (C) in sec-
tion 702(11). 
‘‘(E) DEPUTY
DIRECTOR
FOR
STATE, 
LOCAL, AND TRIBAL AFFAIRS.—The Deputy Di-
rector for State, Local, and Tribal Affairs shall 
be responsible for the activities—
‘‘(i) in subparagraphs (A) through 
(D) of section 702(10); 
‘‘(ii) in section 707, the High Inten-
sity Drug Trafficking Areas Program; and 
‘‘(iii) in section 708, the Counterdrug 
Technology Assessment Center.’’. 
SEC. 103. APPOINTMENT AND RESPONSIBILITIES OF THE 
DIRECTOR. 
(a) SUCCESSION.—Section 704(a) is amended by 
amending paragraph (3) to read as follows: 
‘‘(3) ACTING DIRECTOR.—If the Director dies, 
resigns, or is otherwise unable to perform the func-
tions and duties of the office, the Deputy Director 
shall perform the functions and duties of the Direc-
tor temporarily in an acting capacity pursuant to
subchapter III of chapter 33 of title 5, United 
States Code.’’. 
(b) RESPONSIBILITIES.—Section 704(b) is amend-
ed—
(1) in paragraph (4), by striking ‘‘Federal de-
partments and agencies engaged in drug enforce-
ment’’ and inserting ‘‘National Drug Control Pro-
gram agencies’’; 
(2) in paragraph (7), by inserting after ‘‘Presi-
dent’’ the following: ‘‘and the appropriate congres-
sional committees’’; 
(3) in paragraph (13), by striking ‘‘(beginning 
in 1999)’’; 
(4) by striking paragraph (14) and inserting 
the following: 
‘‘(14) shall submit to the appropriate congres-
sional committees on an annual basis, not later than 
60 days after the date of the last day of the applica-
ble period, a summary of—
‘‘(A) each of the evaluations received by 
the Director under paragraph (13); and 
‘‘(B) the progress of each National Drug 
Control Program agency toward the drug con-
trol program goals of the agency using the per-
formance measures for the agency developed 
under section 706(c);’’; 
(5) in paragraph (15), by striking subpara-
graph (C) and inserting the following: 
‘‘(C) supporting the substance abuse infor-
mation clearinghouse administered by the Ad-
ministrator of the Substance Abuse and Mental 
Health Services Administration and established 
in section 501(d)(16) of the Public Health 
Service Act by—
‘‘(i) encouraging all National Drug 
Control Program agencies to provide all 
appropriate and relevant information; and 
‘‘(ii) supporting the dissemination of 
information to all interested entities;’’; and 
(6) by inserting at the end the following: 
‘‘(16) shall coordinate with the private sector to 
promote private research and development of medi-
cations to treat addiction; 
‘‘(17) shall seek the support and commitment of 
State, local, and tribal officials in the formulation 
and implementation of the National Drug Control 
Strategy; 
‘‘(18) shall monitor and evaluate the allocation 
of resources among Federal law enforcement agen-
cies in response to significant local and regional 
drug trafficking and production threats; 
‘‘(19) shall submit an annual report to Con-
gress detailing how the Office of National Drug 
Control Policy has consulted with and assisted State, 
local, and tribal governments with respect to the for-
mulation and implementation of the National Drug 
Control Strategy and other relevant issues; and 
‘‘(20) shall, within 1 year after the date of the 
enactment of the Office of National Drug Control 
Policy Reauthorization Act of 2006, report to Con-
gress on the impact of each Federal drug reduction 
strategy upon the availability, addiction rate, use 
rate, and other harms of illegal drugs.’’. 
(c) REVIEW
AND CERTIFICATION
OF NATIONAL 
DRUG CONTROL PROGRAM BUDGET.—Section 704(c)(3) 
is amended—
(1) in subparagraph (C)(iii), by inserting ‘‘and 
the appropriate congressional committees,’’ after 
‘‘House of Representatives’’; and 
(2) in subparagraph (D)(ii)(II)(bb), by insert-
ing ‘‘and the appropriate congressional committees,’’ 
after ‘‘House of Representatives’’. 
(d) POWERS
OF
DIRECTOR.—Section 704(d) is 
amended—
(1) in paragraph (9), by striking ‘‘Strategy; 
and’’ and inserting ‘‘Strategy and notify the appro-
priate congressional committees of any fund control 
notice issued in accordance with section 704(f)(5);’’; 
and 
(2) in paragraph (10), by inserting before the 
period the following: ‘‘and section 706 of the De-
partment of State Authorization Act for Fiscal Year 
2003 (22 U.S.C. 229j–1)’’. 
(e) FUND CONTROL NOTICES.—Section 704(f) is 
amended by adding at the end the following: 
‘‘(4) CONGRESSIONAL NOTICE.—A copy of each 
fund control notice shall be transmitted to the ap-
propriate congressional committees. 
‘‘(5) RESTRICTIONS.—The Director shall not 
issue a fund control notice to direct that all or part 
of an amount appropriated to the National Drug 
Control Program agency account be obligated, modi-
fied, or altered in any manner—
‘‘(A) contrary, in whole or in part, to a 
specific appropriation; or 
‘‘(B) contrary, in whole or in part, to the 
expressed intent of Congress.’’. 
(f) DRUG INTERDICTION.—
(1) IN GENERAL.—Section 711 is amended by 
adding at the end the following: 
‘‘SEC. 711. DRUG INTERDICTION COORDINATOR AND COM-
MITTEE. 
‘‘(a) UNITED
STATES
INTERDICTION
COORDI-
NATOR.—
‘‘(1) IN GENERAL.—The United States Inter-
diction Coordinator shall perform the duties of that 
position described in paragraph (2) and such other 
duties as may be determined by the Director with 
respect to coordination of efforts to interdict illicit 
drugs from entering the United States. 
‘‘(2) RESPONSIBILITIES.—The United States 
Interdiction Coordinator shall be responsible to the 
Director for—
‘‘(A) coordinating the interdiction activities 
of the National Drug Control Program agencies 
to ensure consistency with the National Drug 
Control Strategy; 
‘‘(B) on behalf of the Director, developing 
and issuing, on or before March 1 of each year 
and in accordance with paragraph (3), a Na-
tional Interdiction Command and Control Plan 
to ensure the coordination and consistency de-
scribed in subparagraph (A);
‘‘(C) assessing the sufficiency of assets 
committed to illicit drug interdiction by the rel-
evant National Drug Control Program agencies; 
and 
‘‘(D) advising the Director on the efforts 
of each National Drug Control Program agency 
to implement the National Interdiction Com-
mand and Control Plan. 
‘‘(3) STAFF.—The Director shall assign such 
permanent staff of the Office as he considers appro-
priate to assist the United States Interdiction Coor-
dinator to carry out the responsibilities described in 
paragraph (2), and may also, at his discretion, re-
quest that appropriate National Drug Control Pro-
gram agencies detail or assign staff to the Office of 
Supply Reduction for that purpose. 
‘‘(4) NATIONAL INTERDICTION COMMAND AND 
CONTROL PLAN.—
‘‘(A) PURPOSES.—The National Interdic-
tion Command and Control Plan shall—
‘‘(i) set forth the Government’s strat-
egy for drug interdiction; 
‘‘(ii) state the specific roles and re-
sponsibilities of the relevant National Drug
Control Program agencies for imple-
menting that strategy; and 
‘‘(iii) identify the specific resources re-
quired to enable the relevant National 
Drug Control Program agencies to imple-
ment that strategy. 
‘‘(B) CONSULTATION WITH OTHER AGEN-
CIES.—The United States Interdiction Coordi-
nator shall issue the National Interdiction Com-
mand and Control Plan in consultation with the 
other members of the Interdiction Committee 
described in subsection (b). 
‘‘(C) LIMITATION.—The National Interdic-
tion Command and Control Plan shall not 
change existing agency authorities or the laws 
governing interagency relationships, but may in-
clude recommendations about changes to such 
authorities or laws. 
‘‘(D) REPORT TO CONGRESS.—On or be-
fore March 1 of each year, the United States 
Interdiction Coordinator shall provide a report 
on behalf of the Director to the appropriate 
congressional committees, to the Committee on 
Armed Services and the Committee on Home-
land Security of the House of Representatives,
and to the Committee on Homeland Security 
and Governmental Affairs and the Committee 
on Armed Services of the Senate, which shall 
include—
‘‘(i) a copy of that year’s National 
Interdiction Command and Control Plan; 
‘‘(ii) information for the previous 10 
years regarding the number and type of 
seizures of drugs by each National Drug 
Control Program agency conducting drug 
interdiction activities, as well as statistical 
information on the geographic areas of 
such seizures; and 
‘‘(iii) information for the previous 10 
years regarding the number of air and 
maritime patrol hours undertaken by each 
National Drug Control Program agency 
conducting drug interdiction activities, as 
well as statistical information on the geo-
graphic areas in which such patrol hours 
took place. 
‘‘(E) TREATMENT OF CLASSIFIED OR LAW 
ENFORCEMENT SENSITIVE INFORMATION.—Any 
content of the report described in subparagraph 
(D) that involves information classified under
criteria established by an Executive order, or 
the public disclosure of which, as determined by 
the Director, the Director of National Intel-
ligence, or the head of any Federal Government 
agency the activities of which are described in 
the plan, would be detrimental to the law en-
forcement or national security activities of any 
Federal, State, or local agency, shall be pre-
sented to Congress separately from the rest of 
the report. 
‘‘(b) INTERDICTION COMMITTEE.—
‘‘(1) IN
GENERAL.—The Interdiction Com-
mittee shall meet to—
‘‘(A) discuss and resolve issues related to 
the coordination, oversight and integration of 
international, border, and domestic drug inter-
diction efforts in support of the National Drug 
Control Strategy; 
‘‘(B) review the annual National Interdic-
tion Command and Control Plan, and provide 
advice to the Director and the United States 
Interdiction Coordinator concerning that plan; 
and 
‘‘(C) provide such other advice to the Di-
rector concerning drug interdiction strategy and
policies as the committee determines is appro-
priate. 
‘‘(2) CHAIRMAN.—The Director shall designate 
one of the members of the Interdiction Committee to 
serve as chairman. 
‘‘(3) MEETINGS.—The members of the Interdic-
tion Committee shall meet, in person and not 
through any delegate or representative, at least once 
per calendar year, prior to March 1. At the call of 
either the Director or the current chairman, the 
Interdiction Committee may hold additional meet-
ings, which shall be attended by the members either 
in person, or through such delegates or representa-
tives as they may choose. 
‘‘(4) REPORT.—Not later than September 30 of 
each year, the chairman of the Interdiction Com-
mittee shall submit a report to the Director and to 
the appropriate congressional committees describing 
the results of the meetings and any significant find-
ings of the Committee during the previous 12 
months. Any content of such a report that involves 
information classified under criteria established by 
an Executive order, or whose public disclosure, as 
determined by the Director, the chairman, or any 
member, would be detrimental to the law enforce-
ment or national security activities of any Federal, 
State, local, or tribal agency, shall be presented to 
Congress separately from the rest of the report. by 
striking subsection (d) and redesignating subsections 
(e), (f), and (g) as subsections (d), (e), and (f), re-
spectively.’’. 
(2) CONFORMING AMENDMENT TO HOMELAND 
SECURITY ACT OF 2002.—Section 878 of the Home-
land Security Act of 2002 (6 U.S.C. 458) is amend-
ed—
(A) in subsection (c), by striking ‘‘Except 
as provided in subsection (d), the’’ and insert-
ing ‘‘The’’; and 
(B) by striking subsection (d) and redesig-
nating subsections (e), (f), and (g) as sub-
sections (d), (e), and (f), respectively. 
(3) TECHNICAL
AMENDMENTS.—Section 704 
(21 U.S.C. 1703) is amended—
(A) by amending subsection (g) to read as 
follows: 
‘‘(g) INAPPLICABILITY
TO CERTAIN PROGRAMS.—
The provisions of this section shall not apply to the Na-
tional Intelligence Program, the Joint Military Intelligence 
Program, and Tactical and Related Activities, unless such
program or an element of such program is designated as 
a National Drug Control Program—
‘‘(1) by the President; or 
‘‘(2) jointly by—
‘‘(A) in the case of the National Intel-
ligence Program, the Director and the Director 
of National Intelligence; or 
‘‘(B) in the case of the Joint Military In-
telligence Program and Tactical and Related 
Activities, the Director, the Director of Na-
tional Intelligence, and the Secretary of De-
fense.’’; and 
(B) by amending subsection (h) to read as 
follows: 
‘‘(h) CONSTRUCTION.—Nothing in this Act shall be 
construed as derogating the authorities and responsibil-
ities of the Director of National Intelligence or the Direc-
tor of the Central Intelligence Agency contained in the Na-
tional Security Act of 1947 (50 U.S.C. 401 et seq.), the 
Central Intelligence Agency Act of 1949 (50 U.S.C. 403a 
et seq.), or any other law.’’. 
SEC. 104. AMENDMENTS TO ENSURE COORDINATION WITH 
OTHER AGENCIES. 
Section 705 is amended—